Zinc oxide calcium silicate composite attenuates acute tramadol toxicity in mice
Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbi...
Saved in:
Published in | BMC pharmacology & toxicology Vol. 24; no. 1; p. 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
09.02.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model.
Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe
O
) or zinc oxide (30% ZnO) were prepared. The composites' adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration.
The 3% Fe
O
-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha-hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses.
The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. |
---|---|
AbstractList | BACKGROUNDSeizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. METHODSCalcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe2O3) or zinc oxide (30% ZnO) were prepared. The composites' adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. RESULTSThe 3% Fe2O3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha-hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. CONCLUSIONThe calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. Abstract Background Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Methods Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe2O3) or zinc oxide (30% ZnO) were prepared. The composites’ adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. Results The 3% Fe2O3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha–hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. Conclusion The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe O ) or zinc oxide (30% ZnO) were prepared. The composites' adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. The 3% Fe O -containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha-hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. Background Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Methods Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe.sub.2O.sub.3) or zinc oxide (30% ZnO) were prepared. The composites' adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. Results The 3% Fe.sub.2O.sub.3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha-hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. Conclusion The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. Keywords: Adsorption, Antidote, Silicate phases, Nano-microstructure, Toxicity management, Wollastonite Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced seizure cases. Although, diazepam clears these seizures, the risk of central respiratory depression cannot be overlooked. Henceforth, three adsorbing composites were examined in a tramadol acute intoxication mouse model. Calcium Silicate (Wollastonite) either non-doped or wet doped with iron oxide (3%Fe.sub.2O.sub.3) or zinc oxide (30% ZnO) were prepared. The composites' adsorption capacity for tramadol was determined in vitro. Tramadol intoxication was induced in Swiss albino mice by a parenteral dose of 120 mg/kg. Proposed treatments were administered within 1 min at 5 increasing doses, i.p. The next 30 min, seizures were monitored as an intoxication symptom. Plasma tramadol concentration was recorded after two hours of administration. The 3% Fe.sub.2O.sub.3-containing composite (CSFe3), was found to be composed of mainly wollastonite with very little alpha-hematite. On the other hand, hardystonite and wellimite were developed in the 30%ZnO-containing composite (CSZn3). Micro-round and irregular nano-sized microstructures were established (The particle size of CS was 56 nm, CSFe3 was 49 nm, and CSZn3 was 42 nm). The CSZn3 adsorption capacity reached 1497 mg of tramadol for each gram. Tramadol concentration was reduced in plasma and seizures were inhibited after its administration to mice at three doses. The calcium silicate composite doped with ZnO presented a good resolution of tramadol-induced seizures accompanied by detoxification of blood, indicating its potential for application in such cases. Further studies are required. |
ArticleNumber | 9 |
Audience | General |
Author | Kenawy, Sayed H Elgohary, Rania Hamzawy, Esmat M A El-Bassyouni, Gehan T ElShebiney, Shaimaa A |
Author_xml | – sequence: 1 givenname: Shaimaa A surname: ElShebiney fullname: ElShebiney, Shaimaa A email: sa.elshebiney@nrc.sci.eg organization: Narcotics, Ergogenics, and Poisons Department, National Research Centre, 33-El-Buhouth St., 12622, Dokki, Giza, Egypt. sa.elshebiney@nrc.sci.eg – sequence: 2 givenname: Rania surname: Elgohary fullname: Elgohary, Rania organization: Narcotics, Ergogenics, and Poisons Department, National Research Centre, 33-El-Buhouth St., 12622, Dokki, Giza, Egypt – sequence: 3 givenname: Sayed H surname: Kenawy fullname: Kenawy, Sayed H organization: Refractories, Ceramics and Building Materials Department, National Research Centre, 33 El Buhouth St, Dokki, Giza, 12622, Egypt – sequence: 4 givenname: Gehan T surname: El-Bassyouni fullname: El-Bassyouni, Gehan T organization: Refractories, Ceramics and Building Materials Department, National Research Centre, 33 El Buhouth St, Dokki, Giza, 12622, Egypt – sequence: 5 givenname: Esmat M A surname: Hamzawy fullname: Hamzawy, Esmat M A organization: Glass Research Department, National Research Centre, 33 El Buhouth St, Dokki, Giza, 12622, Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36759887$$D View this record in MEDLINE/PubMed |
BookMark | eNptUl1rFDEUHaRia-0f8EEGBPFlar4_XoRS1BYK-qAvvoRsktnNMpOsk0yx_9673bbuislDLifnnJB7z8vmKOUUmuY1RucYK_GhMEQF6hChHUKCyQ49a04I4qgTHOOjvfq4OStljWBJqRQnL5pjKiTXSsmT5tvPmFybf0cfWmcHF-exLXGIzlYA8rjJJUJlaw1pBqy01s0A1MmO1uehraB1sd61MbVjdOFV87y3QwlnD-dp8-Pzp--XV93N1y_Xlxc3neOa1c73OHgcFObaSU8XljKtmBZEOEUxIlwshMcyMETCwlnVO-p84N5RhAJo6GlzvfP12a7NZoqjne5MttHcA3laGjvV6IZgLPKOE617zTjDmlmO2YJy5GzPsaAUvD7uvDbzYgzehQTfGw5MD29SXJllvjVaYyKoAoP3DwZT_jWHUs0YiwvDYFPIczFESi4wY4ID9e0_1HWepwSt2rJgQkhJ8pe1tPCBmPoM77qtqbmQVHCYPdXAOv8PC7YPMArISx8BPxC82xOsgh3qquRhrjGnckgkO6KbcilT6J-agZHZ5s_s8mcgf-Y-fwaB6M1-G58kj2mjfwD-odVG |
CitedBy_id | crossref_primary_10_1016_j_ceramint_2024_04_342 crossref_primary_10_1016_j_ceramint_2024_01_155 |
Cites_doi | 10.15171/apb.2019.013 10.1002/jbm.b.34767 10.1016/j.taap.2016.09.013 10.1016/j.drugalcdep.2012.09.018 10.1006/nbdi.1997.0163 10.1248/cpb.44.1361 10.1002/jnr.23609 10.1016/j.neulet.2008.08.081 10.1007/s42411-018-0010-7 10.1007/s00401-021-02348-6 10.1515/dmpt-2017-0040 10.1136/emj.2009.083162 10.1523/JNEUROSCI.2993-07.2007 10.1177/1073858404263463 10.1007/s40501-018-0149-x 10.1177/0748233713491814 10.1016/j.bbi.2018.02.004 10.2174/1874467210666170704110146 10.1007/BF03161089 10.1016/j.eplepsyres.2015.09.008 10.1680/cc.25929 10.1016/j.ceramint.2019.04.113 10.1016/j.amjmed.2018.04.025 10.3109/15563650.2014.918627 10.36076/ppj.2015/18/395 10.1124/jpet.108.137273 10.3758/BF03193146 10.1016/S0074-7742(08)60279-2 10.1111/j.1742-7843.2012.00874.x 10.1080/08897077.2012.677752 10.1007/s10522-006-9045-7 10.1016/j.ceramint.2019.11.144 10.1592/phco.20.19.1423.34854 10.3109/15563650.2015.1036279 10.1080/15563650.2017.1401080 10.3109/00952990.2015.1014959 10.1146/annurev-med-062613-093100 10.1016/B978-0-7216-0693-4.50007-4 10.1039/c3cs35451b 10.1038/sj.bjp.0703562 10.1097/01.XME.0000449839.69324.71 10.1016/j.neuro.2020.05.002 10.1177/1759091417746521 10.1177/1091581817753607 10.1016/S0022-5347(18)31271-0 10.1080/1556365050014418 10.1016/j.ceramint.2021.11.282 10.1016/S0379-0738(03)00100-2 10.31389/jied.10 10.1172/JCI43195 10.1007/BF03161033 |
ContentType | Journal Article |
Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7U7 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s40360-023-00647-0 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Toxicology Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2050-6511 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_a0dc5299f9454194a514b350caf51633 A736503639 10_1186_s40360_023_00647_0 36759887 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Egypt Germany |
GeographicLocations_xml | – name: Egypt – name: Germany |
GrantInformation_xml | – fundername: ; |
GroupedDBID | -A0 0R~ 3V. 53G 5VS 7X7 88E 8AO 8FI 8FJ AAFWJ AAJSJ ABUWG ACGFS ACIHN ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS ASPBG BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CUY CVF DIK EBD EBLON EBS ECM EIF EMB EMOBN FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E NPM OK1 PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SOJ SV3 UKHRP W2D AAYXX CITATION AFGXO 7U7 7XB 8FK AZQEC C1K DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c594t-df1ed1e8159c7d3ba349849626c8310256b6d17e402ebca8fc3cde5dc300e59c3 |
IEDL.DBID | RPM |
ISSN | 2050-6511 |
IngestDate | Tue Oct 22 15:15:20 EDT 2024 Tue Sep 17 21:34:31 EDT 2024 Fri Oct 25 23:46:34 EDT 2024 Thu Oct 10 21:59:13 EDT 2024 Tue Nov 19 20:52:53 EST 2024 Tue Nov 12 22:42:54 EST 2024 Tue Aug 20 22:15:04 EDT 2024 Fri Nov 22 02:15:14 EST 2024 Sat Sep 28 08:13:54 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Wollastonite Nano-microstructure Adsorption Antidote Silicate phases Toxicity management |
Language | English |
License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c594t-df1ed1e8159c7d3ba349849626c8310256b6d17e402ebca8fc3cde5dc300e59c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912638/ |
PMID | 36759887 |
PQID | 2777780872 |
PQPubID | 2028884 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a0dc5299f9454194a514b350caf51633 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9912638 proquest_miscellaneous_2775614465 proquest_journals_2777780872 gale_infotracmisc_A736503639 gale_infotracacademiconefile_A736503639 gale_healthsolutions_A736503639 crossref_primary_10_1186_s40360_023_00647_0 pubmed_primary_36759887 |
PublicationCentury | 2000 |
PublicationDate | 2023-02-09 |
PublicationDateYYYYMMDD | 2023-02-09 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC pharmacology & toxicology |
PublicationTitleAlternate | BMC Pharmacol Toxicol |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | JS Gardner (647_CR8) 2000; 20 MA Mahdy (647_CR29) 2022; 48 M Ahmadimanesh (647_CR16) 2018; 33 W Zhu (647_CR34) 2018; 69 F Clarot (647_CR37) 2003; 134 TS Zimmer (647_CR55) 2021; 142 MA El-Hadidy (647_CR7) 2014; 21 JG Thundiyil (647_CR12) 2007; 3 MA Mahdy (647_CR26) 2020; 46 C Stein (647_CR41) 2016; 67 TG Smart (647_CR47) 2004; 10 RM Shamloul (647_CR17) 2020; 79 F Faul (647_CR32) 2007; 39 KD Phelan (647_CR33) 2015; 117 E Hamdi (647_CR5) 2013; 34 M Rudy (647_CR54) 2017; 9 C Reichert (647_CR15) 2014; 52 647_CR30 647_CR31 H Potschka (647_CR42) 2000; 131 H Saidi (647_CR46) 2010; 27 R Boostani (647_CR14) 2012; 3 AD Kaye (647_CR2) 2015; 18 S Shadnia (647_CR18) 2012; 111 TM Mohamed (647_CR20) 2015; 31 NM Ryan (647_CR9) 2015; 53 C Lagard (647_CR39) 2018; 56 S Hassamal (647_CR44) 2018; 131 CJ Frederickson (647_CR48) 1989; 31 M Miura (647_CR43) 2007; 27 MM Bassiony (647_CR1) 2015; 41 A Klein (647_CR3) 2019; 1 C Lagard (647_CR38) 2016; 310 647_CR22 647_CR23 647_CR24 Y Song (647_CR51) 2008; 445 V Frazzini (647_CR53) 2006; 7 H Talaie (647_CR13) 2009; 5 D Ciubotariu (647_CR49) 2007; 111 T Alexa (647_CR50) 2015; 93 SO Majekodunmi (647_CR27) 2020; 3 A Kordjamshidi (647_CR56) 2019; 45 647_CR4 N Eizadi-Mood (647_CR19) 2014; 5 C Gérardin (647_CR25) 2013; 42 B Bameri (647_CR40) 2018; 37 647_CR10 KL Cumpston (647_CR21) 2018; 5 RB Raffa (647_CR45) 2008; 325 L Ventura (647_CR11) 2018; 11 MP Cuajungco (647_CR52) 1997; 4 M Mabrouk (647_CR28) 2021; 109 EA Salem (647_CR6) 2007; 177 S Babalonis (647_CR36) 2013; 129 V Jovanović-Čupić (647_CR35) 2006; 44 |
References_xml | – ident: 647_CR30 doi: 10.15171/apb.2019.013 – volume: 109 start-page: 1029 year: 2021 ident: 647_CR28 publication-title: J Biomed Mater Res B Appl Biomater doi: 10.1002/jbm.b.34767 contributor: fullname: M Mabrouk – volume: 310 start-page: 108 year: 2016 ident: 647_CR38 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2016.09.013 contributor: fullname: C Lagard – volume: 129 start-page: 116 year: 2013 ident: 647_CR36 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2012.09.018 contributor: fullname: S Babalonis – volume: 4 start-page: 137 year: 1997 ident: 647_CR52 publication-title: Neurobiol Dis doi: 10.1006/nbdi.1997.0163 contributor: fullname: MP Cuajungco – ident: 647_CR24 doi: 10.1248/cpb.44.1361 – volume: 93 start-page: 1534 year: 2015 ident: 647_CR50 publication-title: J Neurosci Res doi: 10.1002/jnr.23609 contributor: fullname: T Alexa – volume: 445 start-page: 42 year: 2008 ident: 647_CR51 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2008.08.081 contributor: fullname: Y Song – ident: 647_CR31 doi: 10.1007/s42411-018-0010-7 – volume: 142 start-page: 729 year: 2021 ident: 647_CR55 publication-title: Acta Neuropathol (Berl) doi: 10.1007/s00401-021-02348-6 contributor: fullname: TS Zimmer – volume: 33 start-page: 75 year: 2018 ident: 647_CR16 publication-title: Drug Metab Pers Ther doi: 10.1515/dmpt-2017-0040 contributor: fullname: M Ahmadimanesh – volume: 27 start-page: 928 year: 2010 ident: 647_CR46 publication-title: Emerg Med J doi: 10.1136/emj.2009.083162 contributor: fullname: H Saidi – volume: 27 start-page: 9721 year: 2007 ident: 647_CR43 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2993-07.2007 contributor: fullname: M Miura – volume: 10 start-page: 432 year: 2004 ident: 647_CR47 publication-title: Neuroscientist doi: 10.1177/1073858404263463 contributor: fullname: TG Smart – volume: 5 start-page: 301 year: 2018 ident: 647_CR21 publication-title: Curr Treat Options Psychiatry doi: 10.1007/s40501-018-0149-x contributor: fullname: KL Cumpston – volume: 31 start-page: 1325 year: 2015 ident: 647_CR20 publication-title: Toxicol Ind Health doi: 10.1177/0748233713491814 contributor: fullname: TM Mohamed – volume: 69 start-page: 568 year: 2018 ident: 647_CR34 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2018.02.004 contributor: fullname: W Zhu – volume: 11 start-page: 97 year: 2018 ident: 647_CR11 publication-title: Curr Mol Pharmacol doi: 10.2174/1874467210666170704110146 contributor: fullname: L Ventura – volume: 5 start-page: 63 year: 2009 ident: 647_CR13 publication-title: J Med Toxicol doi: 10.1007/BF03161089 contributor: fullname: H Talaie – volume: 117 start-page: 90 year: 2015 ident: 647_CR33 publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2015.09.008 contributor: fullname: KD Phelan – ident: 647_CR23 doi: 10.1680/cc.25929 – volume: 45 start-page: 14126 year: 2019 ident: 647_CR56 publication-title: Ceram Int doi: 10.1016/j.ceramint.2019.04.113 contributor: fullname: A Kordjamshidi – volume: 131 start-page: 1382.e1 year: 2018 ident: 647_CR44 publication-title: Am J Med doi: 10.1016/j.amjmed.2018.04.025 contributor: fullname: S Hassamal – volume: 52 start-page: 629 year: 2014 ident: 647_CR15 publication-title: Clin Toxicol doi: 10.3109/15563650.2014.918627 contributor: fullname: C Reichert – volume: 18 start-page: 395 year: 2015 ident: 647_CR2 publication-title: Pain Physician doi: 10.36076/ppj.2015/18/395 contributor: fullname: AD Kaye – volume: 325 start-page: 500 year: 2008 ident: 647_CR45 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137273 contributor: fullname: RB Raffa – volume: 39 start-page: 175 year: 2007 ident: 647_CR32 publication-title: Behav Res Methods doi: 10.3758/BF03193146 contributor: fullname: F Faul – volume: 3 start-page: 1 year: 2020 ident: 647_CR27 publication-title: Int Res J Pharm Med Sci contributor: fullname: SO Majekodunmi – volume: 31 start-page: 145 year: 1989 ident: 647_CR48 publication-title: Int Rev Neurobiol doi: 10.1016/S0074-7742(08)60279-2 contributor: fullname: CJ Frederickson – volume: 111 start-page: 133 year: 2012 ident: 647_CR18 publication-title: Basic Clin Pharmacol Toxicol doi: 10.1111/j.1742-7843.2012.00874.x contributor: fullname: S Shadnia – volume: 34 start-page: 97 year: 2013 ident: 647_CR5 publication-title: Subst Abuse doi: 10.1080/08897077.2012.677752 contributor: fullname: E Hamdi – volume: 7 start-page: 307 year: 2006 ident: 647_CR53 publication-title: Biogerontology doi: 10.1007/s10522-006-9045-7 contributor: fullname: V Frazzini – volume: 46 start-page: 6581 year: 2020 ident: 647_CR26 publication-title: Ceram Int doi: 10.1016/j.ceramint.2019.11.144 contributor: fullname: MA Mahdy – volume: 20 start-page: 1423 year: 2000 ident: 647_CR8 publication-title: Pharmacother J Hum Pharmacol Drug Ther doi: 10.1592/phco.20.19.1423.34854 contributor: fullname: JS Gardner – volume: 53 start-page: 545 year: 2015 ident: 647_CR9 publication-title: Clin Toxicol Phila Pa doi: 10.3109/15563650.2015.1036279 contributor: fullname: NM Ryan – volume: 5 start-page: 302 year: 2014 ident: 647_CR19 publication-title: Int J Prev Med contributor: fullname: N Eizadi-Mood – volume: 56 start-page: 737 year: 2018 ident: 647_CR39 publication-title: Clin Toxicol doi: 10.1080/15563650.2017.1401080 contributor: fullname: C Lagard – volume: 41 start-page: 206 year: 2015 ident: 647_CR1 publication-title: Am J Drug Alcohol Abuse doi: 10.3109/00952990.2015.1014959 contributor: fullname: MM Bassiony – volume: 67 start-page: 433 year: 2016 ident: 647_CR41 publication-title: Annu Rev Med doi: 10.1146/annurev-med-062613-093100 contributor: fullname: C Stein – ident: 647_CR22 doi: 10.1016/B978-0-7216-0693-4.50007-4 – volume: 42 start-page: 4217 year: 2013 ident: 647_CR25 publication-title: Chem Soc Rev doi: 10.1039/c3cs35451b contributor: fullname: C Gérardin – volume: 131 start-page: 203 year: 2000 ident: 647_CR42 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0703562 contributor: fullname: H Potschka – volume: 21 start-page: 148 year: 2014 ident: 647_CR7 publication-title: Middle East Curr Psychiatry doi: 10.1097/01.XME.0000449839.69324.71 contributor: fullname: MA El-Hadidy – volume: 79 start-page: 122 year: 2020 ident: 647_CR17 publication-title: Neurotoxicology doi: 10.1016/j.neuro.2020.05.002 contributor: fullname: RM Shamloul – volume: 9 start-page: 175909141774652 year: 2017 ident: 647_CR54 publication-title: ASN Neuro doi: 10.1177/1759091417746521 contributor: fullname: M Rudy – volume: 37 start-page: 164 year: 2018 ident: 647_CR40 publication-title: Int J Toxicol doi: 10.1177/1091581817753607 contributor: fullname: B Bameri – volume: 3 start-page: 484 year: 2012 ident: 647_CR14 publication-title: Casp J Intern Med contributor: fullname: R Boostani – volume: 177 start-page: 345 year: 2007 ident: 647_CR6 publication-title: J Urol doi: 10.1016/S0022-5347(18)31271-0 contributor: fullname: EA Salem – volume: 111 start-page: 981 year: 2007 ident: 647_CR49 publication-title: Rev Med Chir Soc Med Nat Iasi contributor: fullname: D Ciubotariu – volume: 44 start-page: 143 year: 2006 ident: 647_CR35 publication-title: Clin Toxicol doi: 10.1080/1556365050014418 contributor: fullname: V Jovanović-Čupić – volume: 48 start-page: 7218 year: 2022 ident: 647_CR29 publication-title: Ceram Int doi: 10.1016/j.ceramint.2021.11.282 contributor: fullname: MA Mahdy – volume: 134 start-page: 57 year: 2003 ident: 647_CR37 publication-title: Forensic Sci Int doi: 10.1016/S0379-0738(03)00100-2 contributor: fullname: F Clarot – volume: 1 start-page: 52 year: 2019 ident: 647_CR3 publication-title: J Illicit Econ Dev doi: 10.31389/jied.10 contributor: fullname: A Klein – ident: 647_CR4 – ident: 647_CR10 doi: 10.1172/JCI43195 – volume: 3 start-page: 15 year: 2007 ident: 647_CR12 publication-title: J Med Toxicol doi: 10.1007/BF03161033 contributor: fullname: JG Thundiyil |
SSID | ssj0000778852 |
Score | 2.3157022 |
Snippet | Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the drug-induced... Background Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the... BackgroundSeizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the... BACKGROUNDSeizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the... Abstract Background Seizures are considered to be the most common symptom encountered in emergency- rushed tramadol-poisoned patients; accounting for 8% of the... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 9 |
SubjectTerms | Acute intoxication Adsorption Analgesics, Opioid - adverse effects Animals Antidote Benzodiazepines Calcium Calcium Compounds Calcium oxide Calcium silicates Composite materials Convulsions & seizures Detoxification Diazepam Drug delivery systems Drug dosages Ferric oxide Hematite Intoxication Iron compounds Iron oxides Laboratory animals Mice Nano-microstructure Nitrates Scanning electron microscopy Seizures Seizures (Medicine) Seizures - chemically induced Seizures - drug therapy Silica Silicate phases Toxicity Toxicity management Tramadol Wollastonite Zinc oxide Zinc Oxide - toxicity Zinc oxides |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hnrggHgUChboSKgdq1evHJjmWiqpCAu2hlSoulmM7IodmK3Yj0X_PjJ3dbsSBCznGY8mZ90QznwE-CBr_KBvH0fc5rl2pucNIxt0M_aSXoY6Ofuh_-z6_vNZfb8zNzlVf1BOW4YEz406dCN6gz2xrbTRW3A4jfKOM8K41mEtknE8hd4qp5INLLO2M3EzJVPPTlUZfLTiGKJ4GLLmYRKIE2P-3W96JS9OeyZ0gdPEUnozZIzvLp34Gj2L_HI4XGX76_oRdPUxTrU7YMVs8AFPfv4DFj673bPm7C5GhaHw33LJVl6fgGPWWUwNXZIS42Q-UgzLnB3yBJ7kl5Ce2xr0e03bW9Yyusd-H64svV-eXfLxRgXtT6zUP7SyGWawwh_FlUI1Tuq50jUWNpwvHMP1p5mFWRiwqqUmqar3yIZrglRAR96iXsNcv-_gamFRRYvATpsUAh2lO0zRGitY7qnl1UAV82nDX3mXgDJsKjmpusywsysImWVhRwGcSwJaSQK_TC1QFO6qC_ZcqFHBI4rN5gnRruvasVJiHKjxkAR8TBRkv8s67cQYBP4lgsCaUBxNKNDo_Xd6oiB2NfmVliU8lqlIWcLRdpp3UyNbH5ZBoTKrBTQGvskZtP1ph8Vaj0y-gnOjahCvTlb77mSDBMcuX6Enf_A82voXHMpmJ5KI-gL31ryG-w8xr3bxPRvYH0M8oYA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZge-GCeBMoYCRUDtSq48cmOaEWtaqQqFaolSoulmM7kEOT0mwk-u-ZcbLZRkjsMR5rHY9n5htnHoR84Jj-kZWWge6zTNlMMQuWjNkU9KQTvggWL_S_nS1PL9TXS305Xrh1Y1jlRidGRe1bh3fkByKDX87zTHy-_s2waxR-XR1baNwnOyKVeb4gO0fHZ6vv0y0Lhzm5FptsmXx50CnQ2ZyBqWIx0ZLxmUWKhfv_Vc937NM8dvKOMTp5RB6OKJIeDmx_TO6F5gnZWw1lqG_36fk2q6rbp3t0tS1QffuUrH7UjaPtn9oHCixydX9Fu3rIhqMYY46BXIFi5c2mRyxKrevhAazkCitA0TXMdQDfad1QbGf_jFycHJ9_OWVjZwXmdKHWzFdp8GnIAcu4zMvSSlXkqgDnxmHjMYBB5dKnWQDnEoOl8spJ54P2TnIeYI58ThZN24SXhAoZBBhBriswdAB3yrLUglfOou-rvEzIp83umuuhgIaJjke-NAMvDPDCRF4YnpAjZMBEicWv44P25qcZZclY7p0GM1oVSqu0UBZAXyk1d7bSAC_hL98h-8yQSTqJsDnMJOBRCYtMyMdIgUIMe-fsmIsAr4TlsGaUuzNKED43H94cETMKf2e2RzUh76dhnIkBbU1o-0ijoy-uE_JiOFHTS0tw4gpQ_gnJZmdttivzkab-FUuDA9oXoFFf_X9Zr8kDEQVAMF7sksX6pg9vAFuty7ejAP0FxggifA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Lb9MwHLamceGCeBMYYCQ0Dszg-NEkB4QGYpqQhnpYpYmL5TgORGLp1jbS-t_z2Um7RexCj4ndJv69vq_6PQh5y0P5R1ZaBt9nmbKZYhaRjNkUftKJqvA2_KF_8mNyPFPfz_TZDtmMOxoOcHkrtQvzpGaLPx-uLtefYfCfosHnk49LBTfMGaIPi7WTDBT-jkBkDCleJwPcj545A-GLQ3gE12BNABubOppbv2YUq2JL_38d943INc6qvBGmju6TewO-pIe9QjwgO759SPanfYPq9QE9va63Wh7QfTq9bl29fkSmP5vW0flVU3kK4bmmO6fLpq-ToyH7PKR4eRp6crZdQKnUug4X8CTnoTcUXWGvA7CnTUvDoPvHZHb07fTrMRtmLjCnC7ViVZ36KvU5UI7LKllaqYpcFaA9LowkA0AqJ1WaedDOkEaV1066yuvKSc499sgnZLedt_4ZoUJ6gfDIdY0QCCBUlqUWvHY2sGJVyYS835yuuehba5hISfKJ6WVhIAsTZWF4Qr4EAWxXhrbY8cJ88csMVmYsr5xGgK0LpVVaKAs4WErNna01gCd-8nUQn-lrTLfGbQ4zCaQq8ZAJeRdXBIXD2Tk7VCnglUKjrNHKvdFKmKUb396oiNlotREZPjnPM5GQN9vbYWdIdWv9vItrdGTpOiFPe43avrQEvSsQFhKSjXRtdCrjO23zOzYNBw8Q8LXP_-vQX5C7ItqDYLzYI7urRedfAoStylfRsv4C_DYprw priority: 102 providerName: Scholars Portal |
Title | Zinc oxide calcium silicate composite attenuates acute tramadol toxicity in mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36759887 https://www.proquest.com/docview/2777780872 https://search.proquest.com/docview/2775614465 https://pubmed.ncbi.nlm.nih.gov/PMC9912638 https://doaj.org/article/a0dc5299f9454194a514b350caf51633 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtd9ll7HveukyD0R1WNbI-IvuYlpYSSDFbC2EXIctyZ1ic0sSw_vd7ku00Zrfl4ID1hGW9r98z7z0h9IX68g-VGwK2zxBhlCAGPBkxMdhJy4rUGf9Bf341ubwRs4Vc7CHZ18KEpH2bVyf17-VJXf0KuZV3Szvu88TG2fwMMA0DuRnvo31wvzshejC_CqI6yfoCmWQyXgsw05SAdyKhtpL44984IOU0ZNLt-KPQtv9f47zjnYaZkzuu6OI5etZhSDxt1_oC7bn6JTrK2ibUD8f4-rGman2Mj3D22J764RXKfla1xas_VeEwMMhWzRKvq7YWDvsMc5_G5bDvu1k3HoliYxu4AStZ-v5PeANzLYB3XNXYH2b_Gt1cnF-fXZLuXAViZSo2pChjV8QuASRjVcFzw0WaiBRCG-uPHQMQlE-KWDkILX2qVFJabgsnC8spdTCHv0EH9ap27xBm3DFwgVSW4OYA7OR5LhktrfGRryh4hL71u6vv2vYZOoQdyUS3bNHAFh3YommETj0DtpS-9XW4sbq_1Z0AaEMLK8GJlqmQIk6FAciXc0mtKSWAS3jkJ88-3daRbhVYTxUHNMphkRH6Gii8CsPeWdNVIsAr-WZYA8rDASWonh0O9yKiO9Vfa6bgl9BEsQh93g77mT6drXarJtDIEInLCL1tJWr70r1gRkgNZG2wK8MR0JPQGLzTi_f_PfMDesqCmjBC00N0sLlv3EcAXZt8BKq2UCP0ZDqd_ZjB_-n5VfZ9FD5hwHUuklFQw7-OHS_v |
link.rule.ids | 230,314,727,780,784,864,885,2102,12056,21388,24318,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELege4CXie9lDGYkNB6YNTe2m-QJbWhTga2qUCdNvFiO7UAelo6lkdh_z52TpouQ6GN8Vh2f7-53zn0Q8p5j-keSGwa6zzBpEskMWDJmxqAnbewyb_BC_2I2mV7Kr1fqqrtwq7uwyrVODIraLS3ekR_FCfxSnibxp5vfDLtG4dfVroXGQ7KFldPViGydnM7m3_tbFg5zUhWvs2XSyVEtQWdzBqaKhURLxgcWKRTu_1c937NPw9jJe8bo7AnZ7lAkPW7Z_pQ88NUzcjBvy1DfHdLFJquqPqQHdL4pUH33nMx_lJWlyz-l8xRYZMvmmtZlmw1HMcYcA7k8xcqbVYNYlBrbwANYyTVWgKIrmGsBvtOyotjO_gW5PDtdfJ6yrrMCsyqTK-aKsXdjnwKWsYkTuREyS2UGzo3FxmMAg_KJGycenEsMlkoLK6zzylnBuYc54iUZVcvK7xAaCx-DEeSqAEMHcCfPcxXzwhr0faUTEfm43l190xbQ0MHxSCe65YUGXujAC80jcoIM6Cmx-HV4sLz9qTtZ0oY7q8CMFplUcpxJA6AvF4pbUyiAl_CX-8g-3WaS9iKsjxMBeFTAIiPyIVCgEMPeWdPlIsArYTmsAeXegBKEzw6H10dEd8Jf681Rjci7fhhnYkBb5ZdNoFHBF1cRedWeqP6lBThxGSj_iCSDszbYleFIVf4KpcEB7cegUXf_v6x98mi6uDjX519m316Tx3EQhpjxbI-MVreNfwM4a5W_7YTpL3yMJWQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLagSIgLYm-gUCOhcqBuHC-T5FgKo7K0yqGVKi6WYzsQicmMOhOJ_nuenWSaiBtzjJ81jt_2vegtCL2jvvwjLTUB26eJ0KkgGjwZ0QnYScNs7rT_oH92Pju9FF-v5NVo1FdI2jdlfdT8Xhw19a-QW7lamHjIE4uLsxPANAzkJl7ZKr6L7kkOQjYK1IMRTiG2k2wok8lm8VqAsaYEfBQJFZbED4HjgJfzkE838kqhef-_Jnrko6b5kyOHNH-EHvZIEh93J36M7rjmCTooulbUN4f44rayan2ID3Bx26T65ikqftSNwcs_tXUY2GTqdoHXdVcRh32euU_mcth332xaj0exNi08gJMsfBcovIG9BiA8rhvsR9o_Q5fzzxcnp6SfrkCMzMWG2CpxNnEZ4BmTWl5qLvJM5BDgGD98DKBQObNJ6iDA9AlTWWW4sU5awyl1sIc_RzvNsnG7CDPuGDhCKitwdgB5yrKUjFZG-_hXWB6hD8PtqlXXREOF4CObqY4tCtiiAlsUjdBHz4AtpW-AHR4sr3-qXgyUptZIcKVVLqRIcqEB-JVcUqMrCRAT_nLfs0911aRbNVbHKQdMyuGQEXofKLwiw90Z3dcjwCv5llgTyr0JJSigmS4PIqJ6A7BWLIVfRrOURejtdtnv9EltjVu2gUaGeFxG6EUnUduXHgQzQulE1ia3Ml0BbQntwXvtePnfO_fR_eLTXH3_cv7tFXrAgsYwQvM9tLO5bt1rQGGb8k3Qt7-r1i57 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Zinc+oxide+calcium+silicate+composite+attenuates+acute+tramadol+toxicity+in+mice&rft.jtitle=BMC+pharmacology+%26+toxicology&rft.au=ElShebiney%2C+Shaimaa+A.&rft.au=Elgohary%2C+Rania&rft.au=Kenawy%2C+Sayed+H.&rft.au=El-Bassyouni%2C+Gehan+T.&rft.date=2023-02-09&rft.issn=2050-6511&rft.eissn=2050-6511&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs40360-023-00647-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s40360_023_00647_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-6511&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-6511&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-6511&client=summon |